2025

Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling
Okonechnikov K, Ghasemi D, Schrimpf D, Tonn S, Mynarek M, Koster J, Milde T, Zheng T, Sievers P, Sahm F, Jones D, von Deimling A, Pfister S, Kool M, Pajtler K, Korshunov A
ACTA NEUROPATHOL COM. 2025;13(1):4.

Author Correction: Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
Smirnov P, Przybilla M, Simovic-Lorenz M, Parra R, Susak H, Ratnaparkhe M, Wong J, Körber V, Mallm J, Philippos G, Sill M, Kolb T, Kumar R, Casiraghi N, Okonechnikov K, Ghasemi D, Maaß K, Pajtler K, Jauch A, Korshunov A, Höfer T, Zapatka M, Pfister S, Huber W, Stegle O, Ernst A
NAT COMMUN. 2025;16(1):1085.

2024

Author Correction: Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage
Ghasemi D, Okonechnikov K, Rademacher A, Tirier S, Maass K, Schumacher H, Joshi P, Gold M, Sundheimer J, Statz B, Rifaioglu A, Bauer K, Schumacher S, Bortolomeazzi M, Giangaspero F, Ernst K, Clifford S, Saez-Rodriguez J, Jones D, Kawauchi D, Fraenkel E, Mallm J, Rippe K, Korshunov A, Pfister S, Pajtler K
NAT COMMUN. 2024;15(1):8597.

Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage
Ghasemi D, Okonechnikov K, Rademacher A, Tirier S, Maass K, Schumacher H, Joshi P, Gold M, Sundheimer J, Statz B, Rifaioglu A, Bauer K, Schumacher S, Bortolomeazzi M, Giangaspero F, Ernst K, Clifford S, Saez-Rodriguez J, Jones D, Kawauchi D, Fraenkel E, Mallm J, Rippe K, Korshunov A, Pfister S, Pajtler K
NAT COMMUN. 2024;15(1):269.

Developmental basis of SHH medulloblastoma heterogeneity
Gold M, Ong W, Masteller A, Ghasemi D, Galindo J, Park N, Huynh N, Donde A, Pister V, Saurez R, Vladoiu M, Hwang G, Eisemann T, Donovan L, Walker A, Benetatos J, Dufour C, Garzia L, Segal R, Wechsler-Reya R, Mesirov J, Korshunov A, Pajtler K, Pomeroy S, Ayrault O, Davidson S, Cotter J, Taylor M, Fraenkel E
NAT COMMUN. 2024;15(1):270.

Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
Smirnov P, Przybilla M, Simovic-Lorenz M, Parra R, Susak H, Ratnaparkhe M, Wong J, Körber V, Mallm J, Philippos G, Sill M, Kolb T, Kumar R, Casiraghi N, Okonechnikov K, Ghasemi D, Maaß K, Pajtler K, Jauch A, Korshunov A, Höfer T, Zapatka M, Pfister S, Huber W, Stegle O, Ernst A
NAT COMMUN. 2024;15(1):.

2023

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
Chapman R, Ghasemi D, Andreiuolo F, Zschernack V, Espariat A, Buttarelli F, Giangaspero F, Grill J, Haberler C, Paine S, Scott I, Jacques T, Sill M, Pfister S, Kilday J, Leblond P, Massimino M, Witt H, Modena P, Varlet P, Pietsch T, Grundy R, Pajtler K, Ritzmann T
NEURO-ONCOLOGY. 2023;25(10):1871-1882.

2022

The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
Ghasemi D, Fleischhack G, Milde T, Pajtler K
CANCERS. 2022;14(3):.

2021

Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas
Zheng T, Ghasemi D, Okonechnikov K, Korshunov A, Sill M, Maass K, Benites Goncalves da Silva P, Ryzhova M, Gojo J, Stichel D, Arabzade A, Kupp R, Benzel J, Taya S, Adachi T, Shiraishi R, Gerber N, Sturm D, Ecker J, Sievers P, Selt F, Chapman R, Haberler C, Figarella-Branger D, Reifenberger G, Fleischhack G, Rutkowski S, Donson A, Ramaswamy V, Capper D, Ellison D, Herold-Mende C, Schüller U, Brandner S, Driever P, Kros J, Snuderl M, Milde T, Grundy R, Hoshino M, Mack S, Gilbertson R, Jones D, Kool M, von Deimling A, Pfister S, Sahm F, Kawauchi D, Pajtler K
CANCER DISCOV. 2021;11(9):2230-2247.

Letzte Aktualisierung aus dem FIS: 22.02.2025 - 06:13 Uhr